[Epidemiology of hepatocellular carcinoma]
- PMID: 8751796
[Epidemiology of hepatocellular carcinoma]
Abstract
Hepatocellular carcinoma (HCC), which constitutes the majority of primary liver cancer, is endemic to certain areas of the world. The incidence rate varies considerably from area to area, and the difference between Mozambique, South Africa, and northern Europe in the age group of 25 to 34 years is more than 500-fold in males. It now seems that the area along the Yangtse River to the north of Shanghai, China, has an incidence rate just as high as Mozambique. Such differences are due to the predominant etiologic factors such as aflatoxin B1, and hepatitis B and C virus infections. While the hepatitis B infection rate is decreasing among HCC patients, hepatitis C infection has been increasing in the population and in HCC patients in some countries, such as Japan, Italy and Spain. Regardless of the area, males are more prone to HCC than females, and this ratio is also changing with time in some countries because of the change in the relative proportion of hepatitis B and C among patients. The known etiologic factors, such as hepatitis B, hepatitis C, Budd-Chiari syndrome and chemical carcinogens, are briefly reviewed.
Similar articles
-
Epidemiology of hepatocellular carcinoma.Oncology. 2010 Jul;78 Suppl 1:7-10. doi: 10.1159/000315223. Epub 2010 Jul 8. Oncology. 2010. PMID: 20616577
-
[Epidemiology of hepatocellular carcinoma].Minerva Gastroenterol Dietol. 1991 Apr-Jun;37(2):73-84. Minerva Gastroenterol Dietol. 1991. PMID: 1660311 Review. Italian.
-
Hepatocarcinogenesis.Trop Gastroenterol. 1990 Jan-Mar;11(1):9-24. Trop Gastroenterol. 1990. PMID: 2162576 Review.
-
Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis.Cancer. 1999 May 15;85(10):2132-7. Cancer. 1999. PMID: 10326690
-
High prevalence of hepatitis B virus infection and inferior vena cava obstruction among patients with liver cirrhosis or hepatocellular carcinoma in Nepal.J Gastroenterol Hepatol. 2007 Nov;22(11):1921-8. doi: 10.1111/j.1440-1746.2006.04611.x. J Gastroenterol Hepatol. 2007. PMID: 17914971
Cited by
-
First-line systemic treatment for hepatocellular carcinoma: A systematic review and network meta-analysis.Heliyon. 2023 Jul 26;9(8):e18696. doi: 10.1016/j.heliyon.2023.e18696. eCollection 2023 Aug. Heliyon. 2023. PMID: 37560704 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical